Keywords: α-CGRP; alpha-calcitonin gene related peptide; Ang; angiopoietin; AE2; anion exchanger 2; ADP; adenosine diphosphate; ADPKD; autosomal dominant polycystic kidney disease; ATP; adenosine triphosphate; ASBT; sodium-dependent bile acid transporter; AQP; aqu
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AD; Alzheimer's disease; PPs; polyphenols; EGCG; epigallocatechin gallate; NFTs; neurofibrillary tangles; ACh; acetylcholine; Aβ; amyloid-beta; APP; amyloid precursor protein; PS-1; presenilin-1; PS-2; presenilin-2; AChE; acetylcholine esterase; Cdk5;
Keywords: FK228 (PubChem CID: 5352062); PXD101 (PubChem CID: 6918638); SAHA (PubChem CID: 5311); LBH-589 (PubChem CID: 6918837); tubacin (PubChem CID: 6675804); tubastatin A (PubChem CID: 49850262); ACY-1215 (PubChem CID: 53340666); ACY-241 (PubChem CID: 53340426);
Keywords: 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: AANAT; arylalkylamine N-acetyltransferase; AE2; Clâ/HCO3- anion exchanger 2; ANIT; α-naphthylisothiocyanate; BA; biliary atresia; BDL; bile duct ligation; cAMP; adenosine 3â²,5â²-cyclic monophosphate; CCA; cholangiocarcinoma; CCl4; carbon tetrachlo
Keywords: AS; activation segment; CS or C-spine; catalytic spine; CL; catalytic loop; CTT; carboxyterminal tail; D1; immunoglobulin-like domain-1; EGFR; epidermal growth factor receptor; GIST; gastrointestinal stromal tumors; GK; gatekeeper; GRL; Gly-rich loop; KD;
Keywords: corneal transplantation; corneal neovascularization; angiogenesis; lymphangiogenesis; VEGF; VEGFR; biomaterial; stem cell;
Keywords: MDR; multi-drug resistance; PPI; polypropyleneimine; RBC; red blood cell; WBC; white blood cell; LDH; lactate dehydrogenase; EPR; enhances permeability and retention; FA; folic acid; FR; FA receptor; SMUT; sodium-dependent multi-vitamin transporter; FITC;
Keywords: ALK1; activin receptor-like kinase1; ANG/Ang; angiopoietin; Bcl-xL; b-cell lymphoma-extra large; BM; bone marrow; BMDCs; bone marrow derived cells; BMP; bone morphogenetic protein; Bv8; bombina variagata peptide 8; CAFs; cancer/carcinoma associated fibrob
Keywords: AGEs; advanced glycation end products; PKC; protein kinase C; DAG; diacylglycerol; ROS; reactive oxygen species; VEGF; vascular endothelial growth factor; VEGFR; vascular endothelial growth factor receptor; ECs; endothelial cells; VSMCs; vascular smooth m
Keywords: EPC; endothelial progenitor cells; VEGFR; vascular endothelial growth factor receptor; vWF; von Willebrand Factor; acLDL; Acetylated-low density lipoprotein; CXCR4; C-X-C chemokine receptor type 4; VEGF; vascular endothelial growth factor; EGF; epidermal
Keywords: VEGF; Vascular Endothelial Growth Factor; MMP; Matrixmetalloproteinases; uPAR; UrokinasePlasminogen Activator Receptor; Ang-1; Angiotensin-1; TGF-β; Transforming Growth Factor-β; VEGFR; Vascular Endothelial Growth Factor Receptor; TKI; Tyrosine Kinase I
Keywords: ACC; American College of Cardiology; acLDL; acetylated-low density lipoprotein; AHA; American Heart Association; ALL; acute lymphoblastic leukemia; ANG1; angiopoietin 1; ATMP; Advanced Therapy Medicinal Product; BM; bone marrow; BMSC; bone marrow-derived
Keywords: CAS; clinical activity score; CD31; cluster of differentiation 31; EC; endothelial cell; LYVE-1; lymphatic vessel endothelial hyaluronan receptor 1; NRP; neuropilin; SEMA-3F; semaphorin 3F; TED; thyroid eye disease; VEGF; vascular endothelial growth facto
Keywords: Pancreatic cancer; Angiogenesis; Vascular endothelial growth factor (VEGF); ANGPT; angiopoietin; BRAF; serine/threonine-protein kinase B-raf; CAF; cancer associated fibroblast; Cdkn2a; cyclin-dependent kinase inhibitor 2A; CI; confidence interval; CSF1R;
Keywords: Ab; antibody; ACT; adoptive cell therapy; ANG; angiopoietin; ATP; adenosine triphosphate; BMDC; bone marrow derived cell; CA4P; combretastatin A phosphate; CAF; cancer-associated fibroblast; CCL2; C-C motif ligand 2; CD; cluster differentiation antigen; C
Keywords: Ang1/2; angiopoietin 1 or 2; BMPR2; Bone morphogenetic protein receptor type 2; CAV-1/2; caveolin-1/2; CHD; congenital heart disease; EC; endothelial cell; ECFC; endothelial colony forming cells; EGR-1; early growth response protein 1; EndoMT; endothelial
Keywords: CAPRI; Ca2+-promoted RAS inactivator; CRMP-2; collapsin response mediator protein-2; CSRD; cysteine/serine-rich domain; CTD; C-terminal domain; ERK; extracellular signal-regulated kinase; FTI; farnesyltransferase inhibitor; FAK1; focal adhesion kinase 1;
Keywords: CBL; casitas B-lineage lymphoma; CtxR; cetuximab-resistant; CtxS; cetuximab-sensitive; CRC; colorectal cancer; EGF; epidermal growth factor; EGFR; epidermal growth factor receptor; EMT; epithelial to mesenchymal transition; EPR; epiregulin; FDA; food and
Keywords: C3G; cyanidin-3-glucoside; COX; cyclooxygenase; DADS; diallyl disulfide; EC; endothelial cell; EGCG; epicatechin-3-gallate and epigallocatechin-3-gallate; EGFR; epidermal growth factor receptor; eNOS; endothelial nitric oxide synthase; FGFR; fibroblast gr
Keywords: Ab; Antibody; ABC; ATP-binding cassette; AIOM; Associazione Italiana di Oncologia Medica; ALCAM; Activated leukocyte cell adhesion molecule; APOD; Apolipoprotein D; AR; androgen receptor; AURKA; Aurora kinase A; AURKB; Aurora kinase B; BCS; Biopharmaceuti
Keywords: Chemotherapy; TNBCtype; Neoadjuvant; PIK3CA; Androgen receptor; TNBC; triple negative breast cancer; pCR; pathological complete response; HR; homologous recombination; EMT; epithelial-mesenchymal-transition; AR; androgen receptor; TILs; tumor-infiltrati
Keywords: AAVA; anti-annexin V antibodies; AECA; anti-endothelial cell antibodies; Ang; angiopoietin; ANGPTL; angiopoietin-like protein; AT1R; antibodies against angiotensin II type 1 receptor; CCR; chemokine receptor; dcSSc; diffuse cutaneous systemic sclerosis; D
Keywords: Blood-brain barrier; Neurovascular unit; Glycolysis; Lactate; Brain development; AGEs; advanced glycation end products; ADP; ribose-adenosine diphosphate ribose; ATP; adenosine triphosphate; BBB; blood-brain barrier; BDNF; brain-derived growth factor; C
Keywords: 3V; ventral third ventricle; BTIII; tubulin beta III isoform; CNS; central nervous system; DG; dentate gyrus of the hippocampus; E; embryonic day; GFAP; glial fibrillary acidic protein; IR; immunoreactivity; LV; lateral ventricle; NeuN; Neuronal Nuclei cl
Keywords: tyrosine kinase inhibitors; diabetes mellitus; c-Abl; PDGFR; VEGFR; EGFR
Keywords: ADAM; A Disintegrin And Metalloprotease Domain; AHR; airway hyperreponsiveness; Ang; angiopoietin; ASM; airway smooth muscle; BALf; bronchoalveolar lavage fluid; bFGF; basic fibroblast growth factor; BM; basement membrane; Col; collagen; CTGF; connective
Keywords: Antibodies; Immunoconjugates; Immunotoxins; Ab; antibody; Ag; antigen; ADCC; antibody-dependent cell mediated cytotoxicity; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; AKT; protein kinase B; APC; antigen-presenting cell; Apo2L/TRAIL; t
Keywords: %ID/g; percent injected dose per gram; 125I-FIAU; 125I-labeled fialuridine; 18F-FDG; 18F-labeled fluorodeoxyglucose; 18F-FLT; 18F-labeled fluorothymidine; 18F-FMT; 18F-labeled D-fluoromethyl tyrosine; ADC; apparent diffusion coefficient; BLI; bioluminesce
Keywords: Colon Cancer; Mouse Model; Tumor Progression; VEGFC; CRC; colorectal cancer; HIBEC; human intestinal blood endothelial cell; HILEC; human intestinal lymphatic endothelial cell; LN; lymph node; LV; lymphatic vessel; MFI; mean fluorescence intensity; SAR; S
Keywords: AKAP; A-Kinase Anchoring Protein; ALL; acute lymphoblastic leukemia; A.S.; activation segment; CDK; cyclin-dependent kinase; CML; chronic myelogenous leukemia; C-spine; catalytic spine; EGFR; epidermal growth factor receptor; FGFR; fibroblast growth facto
Keywords: Development; Growth factor; Invertebrates; PVF; PVR; VEGF; VEGFR;
Keywords: SLRP; small leucine-rich proteoglycan; LRR; leucine-rich repeat; RTK; receptor tyrosine kinase; GAG; glycosaminoglycan; HS; heparan sulfate; HSPG; heparan sulfate proteoglycan; He; heparin; CS; chondroitin sulfate; KS; keratan sulfate; CSPG; chondroitin s
Keywords: 18F-FAZA; 18F-labeled fluoroazomycin arabinoside; 18F-FDG; 18F-labeled fluorodeoxyglucose; 18F-FLT; 18F-labeled fluorothymidine; 18F-HX4; 18F-labeled flortanidazole; 18F-MISO; 18F-labeled fluoromisonidazole; 62Cu-ATSM; 62Cu-labeled diacetyl-bis(N-methylth
Keywords: Breast cancer; HER-2-negative; Resistance; Biologic targeted agent; Combination therapy; ABC; advanced breast cancer; AE; adverse event; AI; aromatase inhibitor; AKT; protein kinase; BC; breast cancer; CDK; cyclin-dependent kinase; CT; chemotherapy; CTLA;
Keywords: Angiosarcoma; VEGF; VEGFR; Caprelsa; Bevacizumab; Citotoxicity
Keywords: Gastric cancer; Esophageal cancer; Targeted therapy; HER2; EGFR; VEGFR; mTOR; c-MET
Keywords: ECM; Extracellular matrix; FGF; Fibroblast growth factor; FGFR; Fibroblast growth factor receptor; GAG; Glycosaminoglycan; GO; Gene ontology; KEGG; Kyoto Encyclopedia of Genes and Genomes; HP; Heparin; HS; Heparan sulfate; LMW; Low molecular weight; MMP;
Keywords: ALI; acute lung injury; ECM; extracellular matrix; EGFR; epidermal growth factor receptor; LPS; lipopolysaccharide; MMP; matrix metalloproteinase; NRTK; nonreceptor tyrosine kinase; PDGF; platelet-derived growth factor; PDGFR; platelet-derived growth fact
Keywords: aFGF; acidic fibroblast growth factor; Ang-2; angiopoietin-2; bFGF; basic fibroblast growth factor; Conc; concentration; FGFR; fibroblast growth factor receptor; G-CSF; granulocyte colony-stimulating factor; GM-CSF; granulocyte-macrophage colony-stimulati
Keywords: ANXA 1; annexin A1; APA; aminopeptidase A; APN; aminopeptidase N; APP; aminopeptidase P; BBB; blood-brain barrier; CT; computed tomography; CREG1; cellular repressor of E1A-stimulated genes 1; DDL4; delta like ligand 4; DLP; dynamin-1 like protein; Eph-
Keywords: BSA; bovine serum albumin; CI; combination index; DRI; dose-reduction index; DTNB; 5,5-dithio-bis (2-nitrobenzoic acid); DMSO; dimethyl sulfoxide; EAC; Ehrlich ascites carcinoma; FBS; fetal bovine serum; GIST; gastrointestinal stromal tumor; GSH; glutathi
Keywords: VEGF; vascular endothelial growth factor; CRC; colorectal cancer; VEGFR; VEGF receptors; PLGF; placental growth factor; HGF; hepatocyte growth factor; Il; Interleukin; Del-1; developmentally-regulated endothelial cell locus 1 protein; FGF; fibroblast grow
Keywords: Guanidine; Sorafenib; Protein kinases; RAF-1; MEK-1; Docking; EGFR; Epidermal growth factor receptor; ERK; extracellular signal-regulated kinase; HB; hydrogen bond; MAPK; Mitogen-activated protein kinase; MEK; Mitogen-activated protein/extracellular signa
Keywords: ACC; acetyl-coenzyme A carboxylases; ACO; acetyl-coenzyme A oxidase; ALT; alanine aminotransferase; APC; adipocyte; AST; aspartate aminotransferase; ATGL; adipose triglyceride lipase; CD68; cluster of differentiation 68; COX-2; cyclooxygenase-2; CPT1; car
Keywords: PlGF; placental growth factor, VEGF, Vascular endothelial growth factor; HCC; hepatocellular carcinoma; VEGFR; vascular endothelial growth factor receptor; TAM; tumor-associated macrophages; WT; wild type; αPlGF; murine anti-PlGF monoclonal antibody; DEN
Keywords: Anti-angiogenesis; Resistance; Targeted therapies; Predictive markers; Autophagy; AKT/PKB; protein kinaseB; BMDCs; bone marrow-derived cells; BVZ; bevacizumab/Avastin; CSC; cancer stem-like cells; EGF; epidermal growth factor; EPC; endothelial progenitor
Keywords: Anti-angiogenesis; Nicotinamide; VEGFR; HUVECs; Receptor tyrosine kinase;
Keywords: Angiogenesis; Antiangiogenic agents; Angiogenic cytokines/peptides; EC; endothelial cells; VEGF; vascular endothelial growth factor; VEGF Receptor; VEGFR; FGF; fibroblast growth factor; EGF; epidermal growth factor; epidermal growth factor receptor; EGFR;
Keywords: Human; Placenta; Preeclampsia; Pregnancy; STAT3; VEGFR; VasculatureNT, normotensive; PE, preeclampsia; JAK-STAT, janus kinase-signal transducers and activators of transcription 3; pSTAT3, activated phosphorylated form of STAT3; VEGF, vascular endothelial